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The increasing interest for hadrontherapy can be attributed 
to the great accuracy of ion beams to target the tumor while 
sparing the surrounding healthy tissues (due to the high dose 
deposition in the Bragg peak and the small angular scattering 
of ions) as well as the potential biological advantage of ions 
for some tumor types compared to photons. 
To keep the benefits of carbon ions in radiotherapy, a very 
high accuracy on the dose location is required. The dose 
deposition is affected by the fragmentation of the incident 
ions that leads to: (i) the consumption of the projectiles with 
their penetration depth in the tissues, (ii) the creation of 
lighter fragments having a different biological effectiveness 
(RBE), (iii) the apparition of a fragmentation tail after the 
tumor. The constraints on nuclear models and/or 
fragmentation cross sections in the energy range used in 
hadrontherapy (up to 400 MeV/n) are not yet sufficient to 
reproduce the local dose deposition with the accuracy 
required in a clinical treatment. 
In this context, two experiments with 95 MeV/n 12C beams 
have been performed by our collaboration in 2011 and 2013 
at GANIL [1,2] to measure the energy and angular  
differential fragmentation cross sections on thin targets of 
medical interest (H, C, Al, O and natTi). In March 2015, a new 
experiment with a 50 MeV/n 12C beam on the same targets 
has been conducted at GANIL. The experimental set-up was 
made of five three stages  telescopes, each composed of two 
Si detectors and one CsI scintillator mounted on rotating 
stages to cover angles from 3° to 39°. 
The analysis of this new experiment is under completion. It 
shows that the angular cross sections for light fragments are 
less forward-focused at 50 MeV/n compared to 95 MeV/n, 
resulting in “flatter” distributions. As shown in Figure 1, 
protons and 4He fragments are dominant on the entire 
angular distribution. At this beam energy, the production of 
alpha particles is higher than protons for angles up to 20° 
compared to 10° at 95 MeV/n. 
However, at the most forward angles, 11B fragments seem to 
compete with the protons production. 
The energy distributions of the fragments at forward angles 
are peaked close to the beam energy showing an emission 
dominated by the quasi-projectile. Comparisons between 
experimental data and Geant4 simulations using different 
inelastic models (such as BIC, QMD and INCL++) show 
important discrepancies. 
Final data as well as comparisons with simulations and the 
previous experiments will be presented during the 
conference. 
 
 
Figure 2: Preliminary angular differential cross section for 
various isotopes, from Z=1 to Z=5 
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Purpose: In radiobiology, the clonogenic survival of cells is 
considered the gold standard assay for assessment of cellular 
sensitivity to ionizing radiation. Towards further 
development of next generation biodosimeters in particle 
therapy, cell-fluorescent ion track hybrid detector (Cell-FIT-
HD) previously engineered by our group 1, 2 was utilized to 
study its feasibility as a tool for investigating the effects of 
clinical beams on cellular clonogenic survival. 
Materials and methods: Tumor cells were grown on the 
fluorescent nuclear track detector (FNTD) in cell culture, 
mimicking the standard procedures for clonogenic assay. 
Cell-FIT-HD was used to detect the spatial distribution of 
particle tracks within colony-initiating cells. The physical 
data were associated to radiation induced foci as surrogates 
for DNA double strand breakages (DSB), the hallmark of 
radiation -induced cell lethality. Long-term cell fate was 
monitored to determine the ability of cells to form colonies.  
Results and conclusion:  We showed that single cells can 
attach and grow as colonies on FNTD surface. Usage of the 
fluorescent and confocal microscopy, together with FNTD 
technology, enabled simultaneous analysis of the microscopic 
beam parameters together with the molecular events within 
colonies, at sub-cellular level.   We report the first successful 
S34  ICTR-PHE 2016 
 
detection of particle traverse within colony-initiating cells at 
subcellular resolution using Cell-FIT-HD. The current work 
represents a proof of principle study for correlation of 
particle traversal with long term colony formation using Cell-
FIT-HD. The entire workflow is established and builds a solid 
foundation for further improvements towards population 
level quantitative analysis.  
 
Keywords: cell-fluorescent ion track hybrid detector, 
clonogenic assay, DNA damage, ion hits 
 
References: 
[1] Niklas, M. et al. Engineering cell-fluorescent ion track 
hybrid detectors. Radiation oncology 8, 141 (2013). 
[2] Niklas, M. et al. Subcellular spatial correlation of particle 
traversal and biological response in clinical ion beams. 
International journal of radiation oncology, biology, physics 
87, 1141-1147 (2013). 
 
69 
43Sc Production Development by Cyclotron Irradiation of 
43Ca and 46Ti 
K. A. Domnanich1,2, C. Müller3, A. Türler1,2, N. P. van der 
Meulen2 
1 Department of Chemistry and Biochemistry, University of 
Bern, Freiestrasse 3, 3012 Bern 
2 Laboratory of Radiochemistry and Environmental Chemistry, 
Paul Scherrer Institute, 5232 Villigen PSI 
3 Center of Radiopharmaceutical Sciences, Paul Scherrer 
Institute, 5232 Villigen PSI 
 
Introduction: The positron-emitter 43Sc is considered to be an 
attractive PET radionuclidic alternative to 44Sc, due to its 
more favourable decay properties. What is more, the lower 
energetic gamma line will result in a lower radiation dose 
burden to the patient and the operator.[1] Together with 
47Sc, which demonstrates therapeutic effect by emitting soft 
β--particles, it can be considered as part of the “matched 
pair” principle, enabling tumour imaging and, following that, 
optimal therapy planning. The production of 43Sc is described 
by different nuclear reactions in literature: 43Ca(p,n)43Sc and 
46Ti(p,α)43Sc [1-3]. The feasibility of both production paths 
was tested at the PSI Injector II cyclotron. 
Materials and Methods: 43Ca and 46Ti targets were prepared 
by mixing enriched 43CaCO3 or 46Ti powder with graphite 
powder, pressed and encapsulated in aluminium. Since 
enriched Ti is only available in oxide form, the reduction of 
46TiO2 to elemental 46Ti powder was performed [4]. The 
43CaCO3 and 46Ti targets were irradiated with protons at 
different energies. Two different chromatographic separation 
methods were used to separate the 43Sc product from the 
respective target material. 
Results: The production of 43Ca(p,n)43Sc yields 43Sc with a 
radionuclidic purity of 66% ,while 44Sc was co-produced with 
33% at the end of separation (EOS). The produced 43Sc was 
used to perform a PET phantom study, indicating promising 
preliminary results for 43Sc being a superior imaging 
radionuclide to its 44Sc counterpart. The labelling of the 
obtained 43Sc with DOTANOC could be performed at a 
maximum specificity of 7 MBq 43Sc/nmol DOTANOC with a 
radiochemical purity of 97 %.  
The production of 46Ti(p,α)43Sc yielded 43Sc of 98.7% 
radionuclidic purity at EOS. The percentage of 44Sc in the 
final product did not exceed 1.2%. The longer-lived 
impurities 44mSc, 46Sc and 48Sc were less than 0.04%. To obtain 
enriched 46Ti target material of higher purity, several 
parameters of the 46TiO2 reduction process, including the 
amount of reducing agent, temperature profile and reaction 
time, were altered. Initial difficulties with  the  processing  
of  the  irradiated  46Ti  target  were  addressed  by  changing  
the irradiation parameters to lower beam intensity and 
prolonged irradiation time. 
Conclusion: Successful production of 43Sc was achieved 
utilizing two activation methods, however, the  43Sc  yield  at  
end  of  bombardment  (EOB)  is  significantly  higher  with  
the 43Ca(p,n)43Sc production route. Nevertheless, the 
expensive target material and a 43Sc product of lower 
radionuclidic purity are drawbacks of this pathway. The 
46Ti(p,α)43Sc production method yields 43Sc of high 
radionuclidic purity. However, the 46Ti preparation of 
reduced target material proved to be labour intensive. The 
significantly lower 43Sc yield at EOB is the focus of further 
optimisation. 
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Microbeam Radiation Therapy (MRT) is a relatively new 
approach in radiation oncology exploiting the dose-volume 
effect by using orthovoltage X-rays on a microscopic scale 
[1]. Arrays of plane parallel beams of typically 50 µm width 
with spacings of a few hundred µm show extraordinary 
normal tissue sparing, while still being capable to ablate 
tumours in preclinical research [2]. 
Purpose: Organ motion has not been an issue in MRT, as long 
as preclinical research was carried out in small samples, such 
as cell cultures and rodents. The possible future treatment of 
human brain tumours using microbeam radiation however 
may be affected by cardio-synchronous tissue pulsation. This 
pulsation, with amplitudes in the order of 100 µm [3], 
induces translational movements of the brain tissue causing a 
blurring of the planned plane-parallel dose pattern of 
microbeams in case of extended exposure times. 
Method: A Monte Carlo study to quantify these effects was 
performed using the Geant4 toolkit. Dose was scored in a 
homogeneous cubic water phantom of 15 cm size on a grid 
with 5 µm resolution perpendicular to the beam. The 
sensitive volume was chosen to have an extension of 1 mm 
along the beam direction in 20 mm depth from the surface, 
which corresponds to the reference dosimetry conditions in 
MRT. The relative statistical uncertainty of the dose (1 
standard deviation) per voxel was between 1% and 1.5% in 
the peak region and between 6% and 9% in the dose valley, 
depending on the evaluated beam configuration and could be 
further reduced by appropriate binning of the raw data. 
Results: Monte Carlo calculations for different geometrical 
microbeam configurations and employed dose rates revealed 
significant changes of the planned dose patterns when 
compared to the static case. The chosen quality indicators of 
our study like peak dose, peak-to-valley dose ratio (PVDR), 
microbeam width, spacing, and penumbra were observed to 
be highly degraded, e.g. the PVDR being reduced by up to 
35%. 
Conclusions: We have demonstrated that the effect of even 
small organ motions occurring at heart rate frequencies in 
the brain can only be tolerated at high dose rates of approx. 
10 Gy/s. For example, a dose rate of 12.3 kGy/s can be given 
as a threshold value if one wants to apply a high peak 
entrance dose of 300 Gy in 3 mm depth for 50 µm wide 
microbeams and a primary beam size of 500 µm 
perpendicular to the scan direction.  For lower dose rates the 
observed deterioration of the microbeam dose patterns is 
likely to destroy the intended dose sparing effect for healthy 
tissues. 
For interlaced microbeam geometries an appropriate gating 
technique could be applied in the future based on the phase 
of the cardiac cycle. 
 
 
